Further analysis of the circulating profiles of the identified proteins revealed that MDH2 and MYL3 could separate BMD patients and controls, whereas CA3 allowed for separation of DMD and BMD patients from each other in both plasma and serum.43 The gene discussed is MYL3; the disease is Duchenne muscular dystrophy.